AlphaStocks
6.0
Consider Buy

Medpace Holdings, Inc. (MEDP)

As of Sep 20, 2026, Medpace Holdings, Inc. (MEDP) scores 6.0/10 on AlphaStocks' five-model composite, #51 of 168 Health Care stocks. At $612, MEDP trades 49% above its model fair value of $410.

Health Care / Life Sciences Tools & Services

S&P MidCap 400

$612.42

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#51out of 168 in Health Care

Is Medpace Holdings, Inc. a Good Investment in 2026?

Medpace Holdings, Inc. (MEDP) scores 6.0 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Lynch model rates Medpace Holdings, Inc. as Strong (PEG 0.6 · Fast Grower). However, the Graham model rates it Caution — Significantly above fair value. Medpace Holdings, Inc. currently trades 49% above its estimated fair value of $410. Medpace Holdings, Inc. ranks #51 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E40.1ROE48.9Market Cap18B

Estimated Fair Value

$410.3549% above

Trading above estimated fair value. P/e of 40x implies high growth expectations.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Strong

PEG 0.6 · Fast Grower

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is Medpace Holdings, Inc. (MEDP) a good investment?
As of Sep 20, 2026, Medpace Holdings, Inc. (MEDP) scores 6.0/10 on AlphaStocks' five-model composite, #51 of 168 Health Care stocks. At $612, MEDP trades 49% above its model fair value of $410. That is a middle-of-the-pack score with no strong signal either way.
What is Medpace Holdings, Inc.'s Piotroski F-Score?
Medpace Holdings, Inc.'s Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is MEDP overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $410, MEDP appears overvalued. The stock currently trades 49% above its estimated fair value. Trading above estimated fair value. P/e of 40x implies high growth expectations.
How does MEDP compare to other Health Care stocks?
Medpace Holdings, Inc. ranks #51 out of 168 stocks in the Health Care sector, placing it in the top 30% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about MEDP?
AlphaStocks evaluates MEDP using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Caution; Lynch: Strong. These models are combined into a single composite score of 6.0/10.

Similar Stocks

BIOILMNAZTA

Compare MEDP with

BIO vs MEDPILMN vs MEDPAZTA vs MEDPFTI vs MEDP

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer